How a Psychopharmacology Clinical Trial Site in the Seattle Area Managed Clinical Trials and Patient Care During the COVID-19 Pandemic

On February 29, 2020 the first known death due to coronavirus disease of 2019 (COVID-19) in Washington State was reported. Governor Inslee declared a state of Emergency on February 29th, 2020; and on March 23, 2020, a stay – at – home order was issued.1 This first death was in a hospital less than 10 miles away from the Northwest Clinical Research Center (NWCRC), an independent multi-specialty psychopharmacology clinical trial center with special focus for geriatric research in Parkinson's and Alzheimer's dementia s.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Brief Report Source Type: research